Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Set Fui Chong currently holds 96,774 shares of BioNexus Gene Lab Corp (BGLC), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, Set Fui Chong has been a net neutral trader of BGLC stock. They have purchased $0 and sold $0 worth of shares.
Set Fui Chong's most recent insider trade was on Aug 13, 2026, when they sold 96,774 shares at $0.00 per share.
Set Fui Chong serves as Chief Financial Officer at BioNexus Gene Lab Corp (BGLC). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Set Fui Chong holds the position of Chief Financial Officer at BioNexus Gene Lab Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Set Fui Chong has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Set Fui Chong was on Aug 13, 2026, when they purchased $0 worth of BGLC shares. This transaction involved 96,774 shares at N/A per share.
Set Fui Chong currently owns 96,774 shares of BioNexus Gene Lab Corp (BGLC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Set Fui Chong's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Set Fui Chong has 1 Form 4 filings on record as an insider at BioNexus Gene Lab Corp.
Set alerts for Set Fui Chong and 40,000+ other insiders.